Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis
Authors:
- Shraga ShanySSShraga Shany
- Daphna AlkalayDADaphna Alkalay
- Julia BerginerJBJulia Berginer
- Samuel DekelSDSamuel Dekel
- Gerald SalenGSGerald Salen
- G.Stephen TintGTG.Stephen Tint
- Dan GazitDGDan Gazit
- 1 January 1993
- journal article
- Published by Elsevier in Metabolism
- Vol. 42 (1) , 69-74
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolismJournal of Bone and Mineral Research, 1988
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- The relative significance of trabecular and cortical bone density as a diagnostic index for osteoporosisPhysics in Medicine & Biology, 1987
- Enhancement of 24,25-Dihydroxyvitamin D Levels in Patients Treated with Continuous Ambulatory Peritoneal DialysisNephron, 1986
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984
- Genetics of cerebrotendinous xanthomatosis (CTX): An autosomal recessive trait with high gene frequency in Sephardim of Moroccan originAmerican Journal of Medical Genetics, 1981
- Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.Journal of Clinical Investigation, 1980
- INTESTINAL ABSORPTION OF 25-HYDROXYVITAMIN D AND OSTEOMALACIA IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1977
- A Biochemical Abnormality in Cerebrotendinous Xanthomatosis IMPAIRMENT OF BILE ACID BIOSYNTHESIS ASSOCIATED WITH INCOMPLETE DEGRADATION OF THE CHOLESTEROL SIDE CHAINJournal of Clinical Investigation, 1974
- The Metabolism of Cholestanol, Cholesterol, and Bile Acids in Cerebrotendinous XanthomatosisJournal of Clinical Investigation, 1973